A myGVHDteam Subscriber asked a question πŸ’­

In Dec 24 I had an allo transplant for MDS. In Dec 2025 I developed GVHD with oral, GIT and skin involvement which improved on steroids and Jakavi. In May 2026 I was admitted with a viral pneumonia. My bone marrow biopsy in August 2026 show 10% blasts +- residual MDS. I am currently on decitibine 5 days IVI in a 28 day cycle and venatoclax 400mg daily

October 1
What Is Steroid-Refractory GVHD? When It’s Time To Consider Progression Therapy Read Article...
myGVHDteam

What is the long-term prognosis given an allo transplant, GVHD with multi-organ involvement, a viral pneumonia admission, and now residual disease showing on biopsy while on active treatment?

This is a genuinely complex situation, and it's completely understandable to want clarity on what lies ahead. The honest answer is Show Full Answer

What is the long-term prognosis given an allo transplant, GVHD with multi-organ involvement, a viral pneumonia admission, and now residual disease showing on biopsy while on active treatment?

This is a genuinely complex situation, and it's completely understandable to want clarity on what lies ahead. The honest answer is that prognosis in this scenario is difficult to generalize β€” it really depends on how well the current treatment cycle brings those blast levels down and how the GVHD behaves going forward.

Here are some factors that are known to influence long-term outlook with chronic GVHD: - Severity and spread of GVHD β€” Multi-organ involvement (oral, skin, GIT) like yours is considered more significant and can affect survival odds
- Response to treatment β€” The fact that steroids and Jakavi improved your GVHD is an encouraging sign
- Infections β€” A viral pneumonia admission is a serious complication, as chronic GVHD weakens the immune system's ability to fight infections
- Residual disease β€” Blasts showing on biopsy adds another layer of complexity to the overall picture

The good news is that treatments are advancing, and people with GVHD are living longer than ever before. Early and active treatment β€” which you are clearly receiving β€” does improve outcomes.

That said, this situation really warrants a very direct, honest conversation with your transplant team. They have access to your full clinical picture and can give you a much more personalized prognosis than any general information can offer. Don't hesitate to ask them specifically about goals of the current treatment cycle and what the next steps look like depending on how you respond.

October 1
All updates must be accompanied by text or a picture.

Related Questions

View All
A myGVHDteam Subscriber asked a question πŸ’­

A myGVHDteam Subscriber asked a question πŸ’­